Filtered By:
Condition: Antiphospholipid Syndrome
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 523 results found since Jan 2013.
Primary antiphospholipid syndrome in a male with myocardial infarction with non-obstructive coronary arteries and a history of stroke
Kardiol Pol. 2022 Dec 22. doi: 10.33963/KP.a2022.0295. Online ahead of print.NO ABSTRACTPMID:36546600 | DOI:10.33963/KP.a2022.0295
Source: Kardiologia Polska - December 22, 2022 Category: Cardiology Authors: Pawe ł Rostoff Dominika Drwi ła-Stec Krzysztof Karwat Ma łgorzata Urbańczyk-Zawadzka Jadwiga Nessler Ewa Konduracka Source Type: research
Case report: MELAS and concomitant presumed antiphospholipid antibody syndrome in an adult woman
Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes, and other features (short stature, headaches, seizures, and sensorineural hearing loss) constitute characteristics of MELAS syndrome. MELAS is a rare condition due to mutations in maternally inherited mitochondrial DNA with levels of heteroplasmy possibly related to late adulthood presentation. A previously reported MELAS case coexisted with presumed Antiphospholipid Antibody Syndrome (APLAS), but the connection between MELAS and a potential APLAS is unclear. A 29-year-old woman presented with mild right-sided sensorimotor symptoms and mixed aphasia in...
Source: Frontiers in Neurology - December 14, 2022 Category: Neurology Source Type: research
Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Challenges of Large Vessel Vasculitis Stroke Patient with Complicated Endovascular Thrombectomy: A Case Report
CONCLUSION: Although autoimmune vasculitis is not listed as an absolute contraindication to endovascular thrombectomy, given the antecedent reports, it is prudent to disclose possible complications to both the patient and family while making the decision.PMID:36474453
Source: Acta Neurologica Taiwanica - December 7, 2022 Category: Neurology Authors: Hsi-Yen Lee Su-O Wang Ya-Wen Ciou Chun-Ching Chiu Yang-Hao Ou Source Type: research
